LeonaBio, Inc. LONA
3.25
(1.74)
(34.87%)
as of 25 Sep
- Market cap
- $54.3M
- P/E
- 0.0×
Follow LONA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
7.01 | 10.38 | 1.88 | 9.70 |
+8 more quarters Free account |
Net Debt/EBITDA |
2.63 | 3.93 | 1.13 | 3.76 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.89 | 0.63 | 0.23 | 0.71 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.71) | (1.10) | (4.54) | (1.18) | |
Cash per Share |
2.15 | 3.56 | 20.66 | 6.40 | |
Shareholders Equity per Share |
1.42 | 2.59 | 6.50 | 6.79 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.42 | 2.59 | 6.50 | 6.79 | |
Free Cash Flow |
(16.96) | (20.90) | (19.40) | (4.67) | |
Working Capital |
46.99 | 62.54 | 41.96 | 24.24 | |
Net Current Asset Value |
31.51 | 46.92 | 25.10 | 23.78 | |
| Other line items | |||||
Quick Ratio |
6.53 | 10.15 | 1.86 | 9.05 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.71) | (1.10) | (4.54) | (1.18) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
1.30 | 1.32 | 2.45 | 0.33 | |
Average Assets |
46.22 | 57.55 | 75.47 | 58.14 | |
Average Common Equity |
32.79 | 43.32 | 36.32 | 42.18 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates